VeraLight
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, VeraLight sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
VeraLight: 10 sponsored US clinical trials, none currently recruiting.
VeraLight sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. The most-studied condition in this pipeline is Diabetes, with 2 trials.
Top-decile sponsor footprint
VeraLight ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
9 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
10 total, page 1 of 1
Point of Service Diabetes Screening Evaluation
NCT01669616
Bias Source of Signal in SCOUT DS
NCT01550328
Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS
NCT01375686
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2
NCT01346046
Evaluation of Low Source of Signal in SCOUT DS
NCT01339637
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes
NCT01346033
Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes
NCT01080157
A Study Comparing Skin Fluorescence to Coronary Artery Calcification
NCT00895427
Screening for Early Evidence of Diabetes
NCT00614783
Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications
NCT01415115
Therapeutic Areas
How the VeraLight archive is shaped
10 indexed studies, none listed as recruiting (0% open); 9 completed (90%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Diabetes (2 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
VeraLight: archived-pipeline peers nationwide
Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
VeraLight sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 archived trials
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this VeraLight page
10 registered trials is a research-attention snapshot, not an endorsement of VeraLight or any single study.
- None of VeraLight's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Diabetes is the condition VeraLight studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
VeraLight pipeline card: 10 registered trials from official public datasets.Report a data error.